Michael Gilmore, PhD , Sir William Osler Professor of Ophthalmology, gave two lectures in December. On December 5, he presented the Annual Neal Groman Lecture at the University of Washington, where he spoke on the origins of leading multidrug resistant hospital pathogens, the enterococci. The...
Ocugen, Inc. has obtained an exclusive worldwide license to develop and commercialize future ophthalmology products based on groundbreaking technology developed by Neena Haider, PhD, Associate Professor of Ophthalmology. Learn about this technology and read the full press release.
The VitreoRetinal Surgery Foundation recognized four trainees with research awards and fellowships, enabling them to pursue research investigations at Mass. Eye and Ear and Schepens Eye Research Institute of Mass. Eye and Ear. The VitreoRetinal Surgery Foundation (VRSF) strives to promote education...
The title of ARVO Fellow is an honor established to recognize current ARVO members for their individual accomplishments, leadership and contributions to the Association. ARVO Fellows serve as role models and mentors for individuals pursuing careers in vision and ophthalmology research and help...
New research findings may lead to development of new therapies to delay or prevent the development of diabetic eye disease. Boston, Mass. — Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear have shown that a slight increase in transforming growth factor beta (TGF-β)...
Improved delivery vector better penetrates the inner ear, also restores balance in a mouse model of Usher syndrome Boston, Mass. — In the summer of 2015, a team at Boston Children’s Hospital and Harvard Medical School reported restoring rudimentary hearing in genetically deaf mice using gene therapy...
Jennie Pouget is visiting us from the University of Toronto, where she is an MD/PhD student under Jo Knight’s mentorship. She has been awarded the prestigious Weston Fellowship and the Fulbright scholarship to come and work with us for the coming year.